PAS
ANIK icon

Point72 Asia (Singapore)’s Anika Therapeutics ANIK Stock Holding History

Point72 Asia (Singapore)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9 Buy
+1
New +$10 ﹤0.01% 856
2025
Q1 		– Sell
-1,223
Closed -$20.1K – 858
2024
Q4 		$20.1K Sell
1,223
-1,699
-58% -$33.5K 0.01% 666
2024
Q3 		$72.2K Sell
2,922
-6,323
-68% -$164K 0.01% 623
2024
Q2 		$234K Sell
9,245
-8,000
-46% -$207K 0.05% 261
2024
Q1 		$438K Buy
17,245
+16,682
+2,963% +$404K 0.11% 188
2023
Q4 		$12.8K Buy
+563
New +$11.7K ﹤0.01% 490

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asia (Singapore)'s ANIK Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Anika Therapeutics (ANIK) in Q3 2025: 1 share worth $9. The stake represents ﹤0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in ANIK as recently as Q4 2024.

Point72 Asia (Singapore) first reported a position in ANIK in Q4 2023 and has held it in 6 quarters since. The position peaked at $438K in Q1 2024. 117 funds tracked by Wall St. Rank hold ANIK as of Q3 2025.

  • Point72 Asia (Singapore) held 1 share of Anika Therapeutics worth $9 as of Q3 2025.
  • Anika Therapeutics was a new Point72 Asia (Singapore) position in Q3 2025.
  • Anika Therapeutics made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #856 holding.
  • Point72 Asia (Singapore) first reported a position in Anika Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • Point72 Asia (Singapore)'s Anika Therapeutics position peaked at $438K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.